|
Delayed
NSE India S.E.
02:11:37 26/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,442.10 INR | +1.75% |
|
+8.81% | +20.11% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 31/07 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 68TCr 710.43Cr 608.76Cr 570.42Cr 521.05Cr 983.34Cr 993.03Cr 6.73TCr 2.62TCr 34TCr 2.67TCr 2.61TCr 1,13200Cr | P/E 2027 * |
29.2x | P/E 2028 * | 24.3x |
|---|---|---|---|---|---|
| Enterprise Value | 64TCr 672.15Cr 575.97Cr 539.69Cr 492.97Cr 930.36Cr 939.53Cr 6.37TCr 2.48TCr 32TCr 2.52TCr 2.47TCr 1,07100Cr | EV / Sales 2027 * |
3.82x | EV / Sales 2028 * | 3.36x |
| Free-Float |
51.04% | Yield 2027 * |
0.16% | Yield 2028 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +2.02% | ||
| 1 week | +8.99% | ||
| Current month | +9.60% | ||
| 1 month | +11.49% | ||
| 3 months | +4.13% | ||
| 6 months | +15.26% | ||
| Current year | +20.30% |
| 1 week | 2,252.1 |  | 2,457.5 |
| 1 month | 2,162 | | 2,457.5 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 86 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.08% | +8.99% | +25.51% | +219.16% | 710.43Cr | |
| -0.06% | +1.06% | +19.99% | +71.91% | 4.84TCr | |
| +1.12% | +1.41% | +54.88% | +122.68% | 3.99TCr | |
| -1.10% | -1.08% | -10.96% | +14.46% | 1.2TCr | |
| +1.57% | +3.36% | +15.56% | +79.98% | 1.18TCr | |
| +0.19% | 0.00% | +30.98% | +150.00% | 918.66Cr | |
| -0.97% | +2.72% | +23.88% | +44.59% | 787.42Cr | |
| +1.30% | +1.26% | +54.43% | -10.73% | 725.43Cr | |
| +0.95% | -8.22% | -39.88% | +16.67% | 526.33Cr | |
| -0.46% | -4.31% | +37.20% | +105.19% | 465.87Cr | |
| Average | +0.45% | +0.21% | +21.16% | +81.39% | 1.53TCr | |
| Weighted average by Cap. | +0.43% | +1.01% | +27.50% | +86.51% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 17TCr 176.14Cr 150.94Cr 141.43Cr 129.19Cr 243.81Cr 246.21Cr 1.67TCr 649.44Cr 8.47TCr 661.38Cr 646.97Cr 28TCr | 19TCr 196.28Cr 168.19Cr 157.6Cr 143.96Cr 271.68Cr 274.36Cr 1.86TCr 723.68Cr 9.44TCr 736.99Cr 720.94Cr 31TCr |
| Net income | 2.31TCr 24Cr 21Cr 19Cr 18Cr 34Cr 34Cr 229.59Cr 89Cr 1.17TCr 91Cr 89Cr 3.86TCr | 2.77TCr 29Cr 25Cr 23Cr 21Cr 40Cr 41Cr 275.25Cr 107.15Cr 1.4TCr 109.12Cr 106.75Cr 4.63TCr |
| Net Debt | -3.65TCr -38Cr -33Cr -31Cr -28Cr -53Cr -54Cr -362.52Cr -141.12Cr -1.84TCr -143.72Cr -140.59Cr -6.1TCr | -4.8TCr -50Cr -43Cr -40Cr -37Cr -70Cr -70Cr -476.89Cr -185.65Cr -2.42TCr -189.06Cr -184.94Cr -8.02TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | ₹2,442.10 | +1.75% | 4,08,811 |
| 25/26/25 | ₹2,400.00 | +0.39% | 6,53,245 |
| 24/26/24 | ₹2,390.70 | +3.14% | 7,10,023 |
| 21/26/21 | ₹2,317.90 | -0.64% | 2,37,421 |
| 20/26/20 | ₹2,332.90 | +3.85% | 5,52,157 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
